February 7, 2026
Evaluation of New Coumarins for Anti-Cancer Activity in HL-60 Cell Line Supported by Molecular Docking, MD Simulation, and Binding Free Energy Calculations
Neutral
Dove Medical Press
Owner:
Informa PLC